Drugs in Pregnancy and Lactation is an A-Z listing of drugs by generic name. Each monograph is a careful and exhaustive summary of the literature as it relates to drugs and their known or possible effects to the fetus in pregnancy and to the baby through lacation. Each monograph is templated to include generic US name, Pharmacologic class, Risk factor, Fetal risk summary, Breast feeding, and References. This edition includes access to the entire contents of the book, which will be updated quarterly, initially.
Essential for ob/gyn physicians, primary care physicians, and any health care provider working with pregnant or postpartum women, Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 12th Edition, puts must-know information at your fingertips in seconds. An easy A-to-Z format lists more than 1,400 of the most commonly prescribed drugs taken during pregnancy and lactation, with detailed monographs designed to provide the most essential information on possible effects on the mother, embryo, fetus, and nursing infant.
Featuring 127 new drug entries, the eighth edition of this popular reference provides practical, reliable information on more than 1,175 drugs that may be used by pregnant and lactating women.
First published in 1981, this book provides obstetrical care physicians with a reference for managing patients using fetal heart rate monitoring as a means of primary surveillance. This third edition updates interpretation of heart rate tracings, includes results from the National Institutes of Health workshop, and includes coverage of fetal pulse oximetry for clarifying the significance of nonreassuring fetal heart rate patterns, and new areas of concern regarding infection resulting from fetal inflammatory response. The authors are all professors of medicine, U. of California, Irvine. Annotation (c)2003 Book News, Inc., Portland, OR (booknews.com).
Fetal heart rate monitoring affects the lives of millions of women and infants every year in the United States alone. Used by all members of the obstetric team - nurses, students, midwives, and physicians – it is the primary method to assess fetal oxygenation in both the antepartum and intrapartum setting. Improving outcomes and promoting patient safety depends upon correct use and interpretation of fetal heart rate monitoring, and is crucial to daily obstetric practice. This fourth edition provides the obstetrical team a framework within which to interpret and understand fetal heart rate tracings and their implications. The text covers key issues as the physiological basis for monitoring, a discussion of fetal hypoxemia and neonatal encephalopathy, instrumentation and pattern recognition. In addition to an in-depth review of the standardized NICHD nomenclature and three-tiered FHR Category approach, there are chapters on intrapartum and antepartum management as well as fetal central nervous system effects on monitor patterns. Since fetal monitoring is primarily a screening tool there are also discussions on the use of backup methods for evaluation of abnormal patterns. This 4th edition also brings the addition of Lisa A. Miller CNM, JD, who provides a nursing and midwifery perspective as well an enhanced legal and risk management review. This new fourth edition includes: Review of neonatal encephalopathy and recent studies on CP Currentinformation and discussion of most recent NICHD panel recommendations, both antepartum and intrapartum New chapter on Pitfalls in EFM Detailed chapter on risk management, liability & documentation New section on fetal maternal hemorrhage Update on new instrumentation Crucial information on maternal/fetal coincidence and FDA warnings All chapters include updated practice tips and clinical implications for the entire obstetric team Plus, with this edition clinicians have access to a companion website with full text and an image bank for fast & simplified clinical review.
Gleria (National Research Council, Italy) and De Jaeger (chemistry, University of Sciences and Technologies, France) present material dedicated to the use of poly(organophosphazenes) in biology, photochemistry, and high energy radiation chemistry. Their use as hybrid materials, flame and fire retardants, blend components, ionic conductors, membranes, and catalysts is also examined. Research on cyclomatrix polyphosphazene for membrane applications, sulfonated polyphosphazene membranes for direct methanol fuel cells, and synthesis and applications of phosphazene compounds is described. Annotation : 2004 Book News, Inc., Portland, OR (booknews.com).
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.